AI Engines For more Details: Perplexityβ Kagi Labsβ Youβ
Bacterial Infections: Cefoperazone is effective against a wide range of Gram-positive and Gram-negative bacteria, including strains resistant to other antibiotics. It is commonly used to treat infections such as pneumonia, urinary tract infections (UTIs), skin and soft tissue infections, intra-abdominal infections, and septicemia.
Respiratory Tract Infections: Cefoperazone may be prescribed to treat respiratory tract infections such as bronchitis and pneumonia caused by susceptible bacteria.
Urinary Tract Infections: Cefoperazone can be used to treat urinary tract infections, including cystitis and pyelonephritis, caused by susceptible bacteria.
Intra-abdominal Infections: Cefoperazone is effective against intra-abdominal infections, including peritonitis and abscesses. It can penetrate well into abdominal tissues and target the causative bacteria.
Skin and Soft Tissue Infections: Cefoperazone may be prescribed for certain skin and soft tissue infections caused by susceptible bacteria, including cellulitis and wound infections.
Septicemia: Cefoperazone can be used to treat septicemia, a severe bloodstream infection, caused by susceptible bacteria.
Surgical Prophylaxis: Cefoperazone may be used prophylactically to prevent surgical site infections in certain procedures, particularly gastrointestinal and abdominal surgeries.
Dosage and Administration: Cefoperazone is typically administered intravenously, either as a bolus injection or by continuous infusion. The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's age, weight, and renal function.
Adverse Effects: Common side effects of cefoperazone may include gastrointestinal symptoms such as diarrhea, nausea, vomiting, and abdominal pain. Allergic reactions, including rash, itching, and swelling, can occur, although they are relatively rare.
Drug Interactions: Cefoperazone may interact with other medications, particularly those that affect renal function or interfere with the absorption of antibiotics. It is essential to review the patient's medication history and potential drug interactions before prescribing cefoperazone.
Resistance: Bacterial resistance to cefoperazone is a concern, particularly in regions where antibiotic use is widespread. Resistance can develop due to overuse or misuse of antibiotics, making treatment less effective over time.
Pediatric and Geriatric Use: Cefoperazone can be used in pediatric and geriatric populations, although dosage adjustments may be necessary based on age, weight, and renal function.
(acebis, bactonis, biorazon, cadcef-s, cedonex, cefazone, cefina-sb, cefmate, cefobactam, cefobet, cefobid, cefoctam, cefoject, cefomax, cefomycin, cefoperazon t3a, cefoperazona richet, cefoperazona sulbactam vitalis, cefoperazona y sulbactam, cefoperazone sigma, cefoperazone/sulbactam kalbe, cefosal, cefozed-s, cefozon, cefrazon, cefrobactum, cefrone, cegava, cegava-tz, dardum, defocef, desri, febactum, fobact forte, fytobact, glortum, haishubi, izone-s, kefbactam forte, lactagard, monoact, myticef, neftum-sb, opsama, paracef, pathocef, pathozone, peracef, peractam, prancef-s, primasef, p-zone, racef-s, razone, razone-es, razover-s, sanbax, soperam, sulcef, sulperazon, sulpermed, twibact-ds, twibact-m, vaxcel cefobactam, vaxone-s, viatran, yazon, yazon plus, zefmic-s, zonamax, zone-s, zoras-sb, zostum, 3cef novo, bactazon, bactizone, bactorus, bakfose, bifotik, c.p.z., cebactam, cebanex, cebid, cefapezone, cefdinex-sb, ceflonic, cefocef, cefolatam, cefon, cefoperazona / sulbactam richet, cefoperazone abipharm, cefoperazone abr, cefoperazone sodium - cspc pharm, cefoperazone yarindo, cefoperazone-heng rui, cefoperazone-zizhu pharm, cefophar, cefortal, cefpar, cefper, cefratam, cepraz, cerazone-s, ceropid, cerozon, da nuo xin, dalipaitan, dardumbact-aversi, decef, dexiao, fanlin, fengpaixin, ferotam, ferzobat, fosular, kai si, kaisheng, kang li shu, lijunpaishu, lijunpaitong, linglanxin, logafox, lyzone, magtam, medocef, naspalun, orizone, pacferatam, peratam, ruipuxin, saifubi, shilexin#144;, simextam, stabactam, stabixin, starmast, sulbacef, sulbazon, sulperazone, sulpezole, sultamugin, sunewtam, supelzon, unizone, wystal, xian bi ta, xian qiang, xianbi, xianbixian, xianjie, xiankang, xianpu, xianshu, xinkuaixin, xinruipuxin, yi mei xin, zetong, zifam cs1, zifam cs2, zotam)
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Parabacteroides distasonis | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive β X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 1.1 | 1.1 | |
Acne | 0.6 | 0.9 | -0.5 |
ADHD | 5.6 | 0.6 | 8.33 |
Age-Related Macular Degeneration and Glaucoma | 1.1 | 0.4 | 1.75 |
Allergic Rhinitis (Hay Fever) | 3.4 | 3.5 | -0.03 |
Allergies | 7.5 | 4.6 | 0.63 |
Allergy to milk products | 2.6 | 1.6 | 0.63 |
Alopecia (Hair Loss) | 1.6 | 1.6 | |
Alzheimer's disease | 7.7 | 7.7 | 0 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 4.3 | 1.5 | 1.87 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription
All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]